Analysis of immune response behavior and agents by vaccination with new coronavirus infections in patients with hematopoietic malignancies
Not Applicable
Completed
- Conditions
- hematopoietic malignancies
- Registration Number
- JPRN-UMIN000044850
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have difficulty or suffering from blood sampling and cannot tolerate multiple blood sampling 2. Patients with a history of vagal reflex 3. Patients who have already been vaccinated with COVID-19 vaccine 4. Patients with a history of SARS-CoV-2 infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method